APA (7th ed.) Citation

Chen, D., Shu, J., Zhang, X., Wang, S., Sun, J., Chong, N., . . . Wang, Q. (2025). Non-steroidal mineralocorticoid receptor antagonist finerenone inhibits peritoneal fibrosis induced by high-glucose dialysate via regulating enhancer of zeste homolog 2 (EZH2) expression. Renal Failure, 47(1), 1. https://doi.org/10.1080/0886022X.2025.2491156

Chicago Style (17th ed.) Citation

Chen, Dandan, Jianqiang Shu, Xinyu Zhang, Simeng Wang, Jingshu Sun, Nannan Chong, Zhikang Sun, Ying Xu, and Qinglian Wang. "Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone Inhibits Peritoneal Fibrosis Induced by High-glucose Dialysate via Regulating Enhancer of Zeste Homolog 2 (EZH2) Expression." Renal Failure 47, no. 1 (2025): 1. https://doi.org/10.1080/0886022X.2025.2491156.

MLA (9th ed.) Citation

Chen, Dandan, et al. "Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone Inhibits Peritoneal Fibrosis Induced by High-glucose Dialysate via Regulating Enhancer of Zeste Homolog 2 (EZH2) Expression." Renal Failure, vol. 47, no. 1, 2025, p. 1, https://doi.org/10.1080/0886022X.2025.2491156.